Risk factors for testicular cancer - differences between pure non-seminoma and mixed seminoma/non-seminoma?

被引:28
|
作者
Aschim, E. L.
Haugen, T. B.
Tretli, S.
Daltveit, A. K.
Grotmol, T.
机构
[1] Oslo Univ Coll, Fac Hlth Sci, N-0130 Oslo, Norway
[2] Univ Hosp, Rikshosp, Dept Obstet & Gynaecol, Androl Lab, Oslo, Norway
[3] Canc Registry Norway, Oslo, Norway
[4] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, Bergen, Norway
[5] Med Birth Registry Norway, Bergen, Norway
来源
INTERNATIONAL JOURNAL OF ANDROLOGY | 2006年 / 29卷 / 04期
关键词
histology; placenta; risk factors; testicular cancer;
D O I
10.1111/j.1365-2605.2005.00632.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The origin of testicular germ cell cancer (TGCC) is believed to be carcinoma in situ cells developed in utero. Clinically, TGCCs are divided into two major histological groups, seminomas and non-seminomas, where the latter group includes non-seminomatous TGCCs with seminomatous components (mixed S/NS TGCC). Recent studies, however, have suggested that non-seminomas and mixed S/NS TGCCs could have certain differences in aetiology, and in this study the TGCCs were divided into three, rather than the conventional two histological groups. A large case-control study was undertaken on data on all live-born boys registered in the Medical Birth Registry of Norway during the period 1967-1998 (n = 961 396). Among these were 1087 TGCC cases registered in the Cancer Registry of Norway until February 2004. We found several risk factors for TGCC, including low parity, low gestational age, epilepsy and retained placenta. Several of the variables studied seemed to be risk factors for specific histological groups, e.g. parity 0 vs. 2 and low gestational age being associated with increased risk of non-seminomas, but not of mixed S/NS TGCC, and low maternal age being associated with increased risk of mixed S/NS TGCC, but not of non-seminomatous TGCC. Therefore, our results might suggest that non-seminomas and mixed S/NS TGCCs have partially different risk factors, whose associations may be obscured by combining these two histological groups. The histological groups were not significantly different, however. Most of our findings on risk factors for TGCC are in agreement with at least some previous studies. An unexplainable exception is low birth weight being associated with reduced risk of TGCC in our study.
引用
收藏
页码:458 / 467
页数:10
相关论文
共 50 条
  • [21] Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours
    Mallik, Saurav
    Qin, Guimin
    Jia, Peilin
    Zhao, Zhongming
    EPIGENETICS, 2021, 16 (02) : 162 - 176
  • [22] Survival differences in non-seminoma testis cancer patients according to race/ethnicity
    Incesu, Reha-Baris
    Barletta, Francesco
    Tappero, Stefano
    Piccinelli, Mattia Luca
    Garcia, Cristina Cano
    Morra, Simone
    Scheipner, Lukas
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    Ahyai, Sascha
    Longo, Nicola
    Chun, Felix K. H.
    de Cobelli, Ottavio
    Terrone, Carlo
    Briganti, Alberto
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    CANCER EPIDEMIOLOGY, 2024, 89
  • [23] THE MANAGEMENT OF NON-SEMINOMA GERM-CELL TESTICULAR-TUMORS IN CHRISTCHURCH
    COLLS, BM
    FITZHARRIS, BM
    ARNOLD, EA
    MCRAE, CU
    GOWLAND, SP
    ATKINSON, CH
    WOLEVER, THS
    FOX, HWJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (04): : 299 - 299
  • [24] Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
    Oldenburg, J.
    Berney, D. M.
    Bokemeyer, C.
    Climent, M. A.
    Daugaard, G.
    Gietema, J. A.
    De Giorgi, U.
    Haugnes, H. S.
    Huddart, R. A.
    Leao, R.
    Sohaib, A.
    Gillessen, S.
    Powles, T.
    ANNALS OF ONCOLOGY, 2022, 33 (04) : 362 - 375
  • [25] Conditional survival of stage III non-seminoma testis cancer patients
    Incesu, Reha-Baris
    Barletta, Francesco
    Tappero, Stefano
    Morra, Simone
    Garcia, Cristina Cano
    Scheipner, Lukas
    Piccinelli, Mattia Luca
    Tian, Zhe
    Saad, Fred
    Shariat, Shahrokh F.
    de Cobelli, Ottavio
    Ahyai, Sascha
    Chun, Felix K. H.
    Longo, Nicola
    Terrone, Carlo
    Briganti, Alberto
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 435.e11 - 435.e18
  • [26] Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer
    Klepp, O
    Dahl, O
    Flodgren, P
    Stierner, U
    Olsson, AM
    Oldbring, J
    Nilsson, S
    Daehlin, L
    Tornblom, M
    Smaland, R
    Starkhammar, H
    Abramsson, L
    Wist, E
    Raabe, N
    Edekling, T
    CavallinStahl, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) : 1038 - 1044
  • [27] Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma
    Looijenga, LHJ
    Rosenberg, C
    van Gurp, RJHLM
    Geelen, E
    van Echten-Arends, J
    de Jong, B
    Mostert, M
    Oosterhuis, JW
    JOURNAL OF PATHOLOGY, 2000, 191 (02): : 187 - 192
  • [28] Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors
    Ykema, Berbel L. M.
    Breekveldt, Emilie C. H.
    Carvalho, Beatriz
    van Wezel, Tom
    Meijer, Gerrit A.
    Kerst, Martijn
    Schaapveld, Michael
    van Leeuwen, Flora E.
    Snaebjornsson, Petur
    van Leerdam, Monique E.
    BRITISH JOURNAL OF CANCER, 2022, 127 (11) : 1991 - 1996
  • [29] New Insights on the Mechanisms Affecting Fertility in Men with Non-Seminoma Testicular Cancer before Cancer Therapy
    Dias, Tania R.
    Agarwal, Ashok
    Pushparaj, Peter N.
    Ahmad, Gulfam
    Sharma, Rakesh
    WORLD JOURNAL OF MENS HEALTH, 2020, 38 (02): : 198 - 207
  • [30] Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors
    Berbel L. M. Ykema
    Emilie C. H. Breekveldt
    Beatriz Carvalho
    Tom van Wezel
    Gerrit A. Meijer
    Martijn Kerst
    Michael Schaapveld
    Flora E. van Leeuwen
    Petur Snaebjornsson
    Monique E. van Leerdam
    British Journal of Cancer, 2022, 127 : 1991 - 1996